COMPANION ANIMAL RISKS OF FLEA AND TICK INSECTICIDES.
This review of current products on the market being sold to kill fleas, ticks and other insects on dogs and cats, assessment of their documented insecticidal action and incidence of harmful side-effects indicates their long-term use for prevention, widely practiced, should be avoided for animal and public health and environmental reasons. Their short-term use in emergency situations of confirmed presence of ectoparasites on companion animals may be justified with caution when all other control measures have failed. Reference is also made to the widespread use of these substances on farmed animals.
Stockholm tar was an old farm remedy for all manner of skin diseases in livestock. It is a distillate from pine wood and was popular in the last century as a hoof dressing and wound protectant. Crushed rock sulfur was often added, along with lard. Creosote, coal tar, tractor sump oil and grease were cheaper but more injurious substitutes for Stockholm tar. These latter petrochemicals were often quite effective however in treating some skin diseases and ectoparasites and became part of the agrichemical revolution after World war 11 that lead to the manufacture of the first generation of chemically engineered pesticides. Petrochemical pesticides have been manufactured and used as dips, powders, sprays, feed-additives and injections for farmed (food) animals, including laying hens and for companion animals.
The latest widely used 'preventive' flea and tick drugs that are given orally or are injected or put on the skin and absorbed transdermally, are said to be safer for companion animals than organochloride and other petrochemical pesticides. But they too can compromise the liver, immune and neuroendocrine systems of already immuno-compromized dogs suffering from the harmful side effects of prior drugs and vaccines, signs being more severe in some breeds than others. The increased incidence of seizures in dogs and cats I believe correlates with the increased use of fiprinil and other insecticides regularly applied to companion animals across the world. At least one dog had seizures when actually taken off fiprinil-containing Front Line flea and tick treatment, a rarely reported withdrawal effect.
The US government's Environmental Protection Agency (EPA)announced in May 2009 that it would conduct a thorough investigation of topical anti-flea and tick products used on dogs and cats after some 44,000 reports of adverse reactions were received by the EPA in 2008. Since that time there has been little done except adding more details on packaging with regard to application and possible adverse reactions.
I have received many letters over the past two decades from readers of my nationally syndicated newspaper column Animal Doctor whose cats and dogs had adverse reactions to various flea and tick treatments. One commonly seen pet reaction is panic which, as an ethologist, I interpret as a state of terror caused by the neuro-excitatory effects of some insecticides, sometimes manifest also as transient tremors and ataxia, other times permanent damage with epileptiform seizures or death. Many are carcinogens and endocrine disruptors as well and may contribute to the increasing incidence of cancer and diseases of the thyroid and adrenal glands in dogs and cats, if not also to cognitive and behavioral problems.
I was surprised to receive my Veterinary Record professional journal from the British Veterinary Association (June 30, 2018.Vol 182 No 26).) with a 4-page glossy color advertisement wrapped around the cover page from Bayer (that now owns Monsanto) promoting Seresto, offering "up to 8 months of protection" for cats and dogs from fleas and ticks using another insecticidal concoction. The Seresto collars contain the synthetic pyrethroid flumethrin which has a similar mode of action as organochlorines to both of which felines are especially sensitive.
Pyrethroids act on the membrane of nerve cells blocking the closure of the ion gates of the sodium channel during re-polarization. This strongly disrupts the transmission of nervous impulses, causing spontaneous depolarization of the membranes or repetitive discharges. At low concentrations insects and other arthropods suffer from hyperactivity. At high concentrations they are paralyzed and die. In mammals flumethrin can cause nausea, vomiting and seizures among other harmful side effects.
The other Seresto ingredient is imidacloprid, a neonicotinoid acting as a nicotinic acetylcholine receptor (nAChR) agonist with potent insecticidal activity. Since its introduction in the early 1990s, imidacloprid has become one of the most extensively used insecticides for both crop protection and animal health applications and is implicated in the demise of the honey bee. Imidacloprid can cause seizures, thyroid gland damage, mutations, abortions and birth defects, (and is a class of widely used agricultural chemicals implicated in the catastrophic demise of honey bees, banned by the European Commission in 2013 for 2 years in Europe). There is also the concern of children and adults petting animals with these chemicals seeping over the animals' skin, and of the animals grooming themselves and each other.
Bayer is now marketing a plethora of insecticidal products world-wide. The products within the "Bayer Pest Solution Center" are organized into three categories: Prevent, Treat, Control. The prevention section comprises three Bayer lines – K9 Advantix® II, Seresto® and Advantage® II - while the treatment and control sections feature Bayer's new products. Bayer is also supporting pet specialty retailers with training modules and toolkits for employees to enable them to help their customers. These new products containing similar ingredients include - Advantage® Treatment Spray for dogs, Advantage® Treatment Spray for cats, Advantage® Treatment Shampoo for dogs, and Advantage® Treatment Shampoo for cats and an array of Advantage™ Household Spot & Crevice Spray, Advantage™ Carpet & Upholstery Spot Spray, and Advantage™ Household Fogger to kill indicated pests in the home, and Advantage™ Yard & Premise Spray that kills pests in the yard and around the house.
It should be noted that there is no guarantee of animals not developing allergic reactions to flea and other insect bites, or from contracting an insect-born disease, the company stating: "Advantix® provides repellent (anti-feeding) activity against ticks, sand flies and mosquitoes, thus preventing the repelled parasites from taking a blood meal and thus reducing the risk of disease transmission (e.g. Lyme borreliosis, babesiosis, anaplasmosis, ehrlichiosis, rickettsiosis, leishmaniosis). However, there may be an attachment of single ticks or bites by single sand flies or mosquitoes. For this reason, a transmission of infectious diseases by these parasites cannot be completely excluded if conditions are unfavourable….. Following topical application in dogs, the solution rapidly distributes over the body surface of the animal. Both active substances remain detectable on the skin and hair of the treated animal for 4 weeks…. Acute dermal studies in the rat and target animal, overdose and serum kinetic studies have established that systemic absorption of both active substances after application on intact skin is low, transient and not relevant for the clinical efficacy". Why no long-term studies?
Elanco's broad spectrum parasiticide Trifexis® (spinosad + milbemycin oxime) is the monthly, beef-flavored tablet marketed to kill fleas and prevents flea infestations, prevents heartworm disease, and treats and controls adult hookworm, roundworm and whipworm infections in dogs. The company states that "Trifexis is safe for use in dogs and puppies 8 weeks of age or older and 5 pounds of body weight or greater. (Comfortis is Elanco's product for cats consisting only of spinosad). Treatment with fewer than three monthly doses after the last exposure to mosquitoes may not provide complete heartworm prevention. Prior to administration of Trifexis, dogs should be tested for existing heartworm infection. Use with caution in breeding females. The safe use of Trifexis in breeding males has not been evaluated. Use with caution in dogs with pre-existing epilepsy. The most common adverse reactions reported are vomiting, depression/lethargy, itching, decreased appetite, and diarrhea".
In one study rats given 0.05% spinosad for 2 years had vacuolation and/or inflammation involving the thyroid, lymphoid tissue, and lung. The spinosyns and spinosoids have a novel mode of action, primarily targeting binding sites on the nicotinic acetylcholine receptors ( nAChRs) of the insect nervous system that are distinct from those at which other insecticides have their activity. Spinosoid binding leads to disruption of acetylcholine neurotransmission. Spinosad also has secondary effects as a γ-amino-butyric acid (GABA) neurotransmitter agonist. It kills insects by hyperexcitation of the insect nervous system.
Milbemycin oxime is produced by Streptomyces hygroscopicusaureolacrimosus. It opens glutamate sensitive chloride channels in neurons and myocytes of invertebrates, leading to hyperpolarization of these cells and blocking of signal transfer. Milbemycin oxime is active against a broad spectrum of nematodes. Its miticide spectrum includes Sarcoptes and Demodex. The drug is FDA-approved for prevention of heartworm in dogs and cats, although it is less potent against heartworms than ivermectin. The substance is often combined with other parasiticides to achieve a broader spectrum of action. Such products include: Milbemax and Interceptor Plus (with praziquantel). Sentinel Flavor Tabs (with lufenuron), Trifexis (with spinosad) ,and NexGard Spectra (with afoxolaner).
(These entries from the Internet illustrate the wide range of biocidal properties of these chemical compounds).
The British government authority that approves drugs for veterinary use in the U.K. has advised that Merck's Bravecto chewable tablets of all sizes must have a label warning: "Use with caution in dogs with pre-existing epilepsy." (The Veterinary Record, Sept. 2017, p.340). The warning from the manufacturer posted in the U.S. does not yet include this and reads: "The most frequently reported adverse reactions include vomiting or diarrhea. Other side effects that may be seen include decreased appetite, lethargy, increased thirst, and flatulance.(sic). Consult your veterinarian if you notice any of the above side effects. Bravecto is for use only in dogs". Another entry states: "The most common adverse reactions recorded in clinical trials were vomiting, decreased appetite, diarrhea, lethargy, polydipsia, and flatulence. Bravecto has not been shown to be effective for 12-weeks' duration in puppies less than 6 months of age. Bravecto is not effective against lone star ticks beyond 8 weeks of dosing".
Hartz's flea and tick products for dogs and cats, marketed widely in drug and grocery stores, are available in sprays, shampoos, collars, and topical spot-on applications. Ingredients variously include: Tetrachlorovinphos,( a highly toxic organophosphate in the EPA's category of probable carcinogens); S-Methoprene, ( an insect growth and metamorphosis disruptor); Etofenprox, ( a pyrethroid ether), Piperonyl Butoxide (PBO), ( an enhancer or synergist of various pesticides especially pyrethrins); n-octyl bicycloheptene dicarboximide (MGK 264), ( another synergist); and Pyriproxyfen (NylarPyriproxyfen), ( may have effects on the blood and liver leading to anemia, impaired functions and tissue lesions and was reported to have some estrogenic activity in human ovarian carcinoma cells. It is a potent insect growth and metamorphosis disruptor), and Phenothrin (also called sumithrin and d-phenothrin, a synthetic pyrethroid).
This industry advocates year-round use for life for companion animals. Long-term effects on food animals are a non-issue since most live very short lives before slaughter. But because of the billions of farmed animals being given insecticides and anti-parasiticides the long-term harmful environmental consequences are considerable. (Manure runoff, including glyphosate and other herbicide residues from feed and fields along with other pesticides, have killed off many aquatic species of Trichoptera and other fresh water organisms, indicators of water quality, and, along with chemical fertilizers, have made lake waters toxic with Blue-green, Cyanobacteria algal blooms).
The adverse environmental impact of insecticide residues in animals' excrement on scatophagous and other insects and dependent insectivores, avian, reptilian and amphibian, is incalculable. These drugs are used world-wide by the livestock and poultry industries along with antibiotics and other production-enhancing drugs and hormones that contaminate the environment and kill waste-recycling organisms. This disrupts the nexus of bio-cycles of ecosystem recycling and regeneration. All such excrement from treated animals should be collected for biodegradation/bioremediation in manure containment or non-leaching land-fill facilities. Many different chemicals and pharmaceutical products are also in our dogs' feces and urine, as well as in our own, from prescription drugs to some manufactured pet food ingredients and contaminants that make such waste harmful to the organisms that make for healthful, living soils and inevitably our water quality. It should, therefore, be a public offense in every community to not pick up after one's dog has defecated in any public open space.
Far too many dermatological problems in dogs especially---and a cause of much animal suffering---could be prevented because they are man-made; consequences of genetic susceptibility, iatrogenic veterinary problems, manufactured pet foods and toxic home environments. Many such factors impair the immune system leading to inflammatory, autoimmune and allergic diseases. Thirty percent of food-allergic dogs and cats are found to have another allergic skin condition according to the 2018 Sate of Pet Health report from Banfield Pet hospital. ( www.StateofPetHealth.com/allergies). Significantly, flea allergy has increased by 12.5 percent in dogs and 76.3 percent in cats over the past decade.
This is a driver for marketing unsafe systemic insecticides as profitable preventives for veterinarians to prescribe for their companion animal clients. But it would not be more ethical and responsible for veterinarians to avoid promoting these insecticides and pandering to convenience and expediency, but rather, educate clients on integrative pest control, a challenge but urgent issue with climate change: Also to encourage clients and communities to keep cats strictly indoors; and to always use a flea comb after taking the dog to the woods during tick season, along with proper nutrition and removing toxic chemicals and other petrochemical-derived synthetic materials from the home environment. Land owners can also employ Guinea fowl to control ticks.
The widespread over-use of insecticides and other anti-parasitic drugs to protect livestock in particular, (now being considered for human use in malaria and other insect-born disease "hot spots") has resulted in the evolution of resistant strains, often more virulent and numerous where there is little natural biodiversity to regulate their numbers. Individual and ecosystem health correlate with optimal biodiversity. This creates the treadmill for ever more potent chemicals and combinations thereof.
While Stockholm tar is not applicable to companion animals, essential oils derived from pine and other botanicals are less toxic alternatives to fiprinil and other synthetic insecticidal and biocidal chemical compounds when properly formulated and applied and many veterinarians are now offering these to their clients such as PetzLife's Herbal Defense and home prepared lemon rind tea sprits as effective insect repellants.
The use of systemic insecticides like fiprinil and fluralaner on companion animals puts those living with them at risk, especially children and other animals in the same home who make contact with treated animals. Therefore, for public as well as legitimate and self-evident animal and environmental health reasons these insecticides should be prohibited for use except by public health and veterinary authorities in times of justified One Health emergency intervention and for bioremediation in ecosystem health care maintenance and recovery to optimize biodiversity.
Since there are dozens of companies marketing these chemicals from Hartz Ultra Guard and Sentry to Zodiac Spot On and ShieldTech for Cats, a blanket prohibition by responsible government of private use on companion animals is surely called for. For companion animals the use should be by prescription only under veterinary supervision. Company by company class-action law-suits by plaintiffs whose animals have suffered adverse reactions including seizures and death from any one of these products sold over the counter and supplied by veterinarians for the highly promoted and widely marketed long-term prevention of ectoparasites may help lower but not stop misuse and adverse consequences .More informative product labeling of risks is the U.S. government's response, the FA posting on Sept 20, 2018, that it "is alerting pet owners and veterinarians to be aware of the potential for neurologic adverse events in dogs and cats when treated with drugs that are in the isoxazoline class. Since these products have obtained their respective FDA approvals, data received by the agency as part of its routine post-marketing activities indicates that some animals receiving Bravecto, Nexgard or Simparica have experienced adverse events such as muscle tremors, ataxia, and seizures. Another product in this class, Credelio, recently received FDA approval. These products are approved for the treatment and prevention of flea infestations, and the treatment and control of tick infestations. The FDA is working with manufacturers of isoxazoline products to include new label information to highlight neurologic events because these events were seen consistently across the isoxazoline class of products".
The situation concerning the over-use and risks, especially environmental, and to aquatic life in particular, is similar in the U.K. Veterinarians K. Powell et al (2018) cite studies raising concerns about pyrethroids, avermectins and the 68 registered products containing neonicotinoids, concluding that "one river-swimming dog treated with a spot-on compound can destroy an ecosystem, and advise treated livestock be put in "sacrificial paddocks" for 3-4 days to protect the rest of the farmland from contamination, , most ivermectin and deltamethrin being excreted within the first 4 days after application.
Dysbiotic intestinal, aquatic and terrestrial microbiomes are ecologically interconnected. The contribution of antiparasitic agents to such dysbiosis on several trophic levels needs to be seen from a One Health perspective and eco-systemic loss of biodiversity which all responsible parties, from manufacturers and suppliers to users and regulators need to address at home and abroad.
In the U.S. regulation of these pesticides is divided between two agencies. According to the Food and Drug Administration's website "Flea and tick products for pets are regulated by either Food and Drug Administration or the Environmental Protection Agency (EPA). FDA is responsible for regulating animal drugs; however, some products to control external parasites come under the jurisdiction of EPA. FDA and EPA work together to ensure adherence to all applicable laws and regulations. In general, flea and tick products that are given orally or by injection are regulated by FDA. Before an animal drug is allowed on the market, FDA must "approve" it. Before a pesticide can be marketed, EPA must "register" it. Both agencies base their decision on a thorough review of detailed information on the product's safety and effectiveness provided by the manufacturer or other product sponsor".
EPA Evaluation of Pet Spot-on Products: Analysis and Plans for Reducing Harmful Effects ( From https://www.epa.gov/pets/epa-evaluation-pet-spot-products-analysis-and-plans-reducing-harmful-effects).
EPA found that the products could be used safely but that some additional restrictions are needed. EPA's team of veterinarians learned that most incidents were minor, but unfortunately some pet deaths and "major incidents" have occurred. The Agency learned that the most commonly affected organ systems were skin, gastrointestinal (digestive), and nervous.
the amount of product in a single dose needed to vary more for small to large dogs; that is, how much the dog weighs matters a lot in deciding how much of a product should be used.
label warnings against use of dog products on other animals, especially cats, are not working well enough, which appears to be a global concern.
Safety Testing: The team also found that the data we now require to determine the safety of these products for pets do not accurately predict the toxicity seen in the incidents that took place. (italics mine).
The division of regulatory and approval authority between the FDA and EPA facilitates the continued marketing of many of these products even after the sellers and manufacturers have been informed of thousands of adverse reactions in dogs and cats as well as many fatalities. The fundamental question of the health consequences of long-term/lifetime use of these insecticides on companion animals has not been addressed by the manufacturers but may be a significant factor in the rising incidence of cancer and other chronic, degenerative and systemic diseases in dogs and cats. It should be noted that fleas and ticks carrying disease could infect dogs and cats on whom they feed before they are killed by these chemicals, flea bites also triggering allergic reactions in many animals.
and yourpetsneedthis.com and facebook.com/groups/411371212394679/. Also https://www.change.org/p/petition-for-the-immediate-withdrawal-of-simparica-flea-tick-treatment-from-the-market and Beware of Seresto flea collars - Page 1 - Pedigree Database www.pedigreedatabase.com/community.read?post=859429-beware-of-seresto-flea...Mar 10, 2016.
Jennings KA1, Canerdy TD, Keller RJ, Atieh BH, Doss RB, Gupta RC. Human exposure to fipronil from dogs treated with frontline. Vet Hum Toxicol. 2002 Oct;44(5):301-3.
This investigation determined fipronil residues on gloves worn while petting dogs after Frontline application. Repeated exposure to such contamination can pose human health risks.
Powell, K., Foster, C., and Evans, S. Environmental dangers of veterinary antiparasitic agents, Veterinary Record, Nov.17th, 2018, p 599-600.
Reduction in clinical cases of vector-borne diseases is strongly dependent on the ability to reduce the number of infectious insect bites. Here we describe a treatment concept based on single-dose administration of an insecticidal isoxazoline drug to a human population, which leads to killing of blood-fed insect vectors and a predicted sharp decline in disease transmission. Based on the long half-life observed in preclinical species, a single human dose of <500 mg is predicted to provide plasma exposure above the insecticidal threshold for longer than 2 months. Importantly, we show that isoxazolines are active against a range of vector species, which holds promise for expanding the concept of drug-based vector control from malaria to leishmaniasis and arboviral diseases.
The author appreciates the helpful suggestions of Dr. W. Jean Dodds in preparing this review.


Welcome to Shenzhen Linx Technology Co., Ltd.
Do you know Headphones style or price which is more important?
We introduce LINX new Bluetooth V5.0 IPX8 waterproof large-capacity charging box, true wireless TWS C3.
Shenzhen LINX Technology Co., Ltd. specializes in producing all kinds of headphones, BSCI, WCA, ISO9001, ISO14001 certified manufacturers, including mobile phone headsets, computer headsets, Bluetooth headsets, cartoon headphones and so on. Welcome online consultation or visit the factory.
© Copyright 2014 Shenzhen Linx Technology Co., Ltd. All rights reserved!


Master Stylist and CEO of MACSTYLE Inc.
Marvin A. Carrington began his career in the hair industry 31 years ago. He is an original product of John Atchinson training, which has allowed him to branch out into management, educational directing and style directing in some of the top salons in New York City.
Marvin has worked for Soft Sheen, Affirm, Mizani, Loreal and as an instructor for Joico Hair Color teaching innovative techniques to New York City salons. He is a high fashion stylist with a soft touch whose work has been featured in Essence, Ebony, Lucky, Honey, Redbook, Latina, Heart and Soul and many other publications. His work has also appeared on ABC and NBC television as well as numerous websites all over the country.


text:
In a roundtable discussion moderated by Dr. Atul Gawande, three experts in health economics — Drs. Elliott Fisher, Jonathan Gruber, and Meredith Rosenthal — explore the most promising ways of slowing the growth of health care costs, their potential effects on medical practice, and the likelihood that the current healthcare reform effort will be a step in the right direction. The transcript of the session is below.
Perspective Roundtable: The Cost of Health Care
DR. ATUL GAWANDE: Welcome to a Perspective Roundtable from the New England Journal of Medicine. I'm Atul Gawande, a staff surgeon at Brigham and Women's Hospital and an associate professor of surgery at Harvard Medical School and of health policy and management at theHarvard School ofPublicHealth.
One of the key goals of the current health care reform effort in our country is to achieve universal health coverage. But everyone agrees that it will be impossible to afford health care for all, even afford it for those who have it now, if we don't find a way to contain our very high and rapidly rising health care costs. Today, we want to discuss the economic dimension of health care reform. How can we reduce overall health care spending, or at least its growth, before it bankrupts the country?
With me here to discuss the economics of health care reform are Elliott Fisher, a professor of community and family medicineat Dartmouth Medical School and director of theCenterforHealth Policy Research at theDartmouth Institute for Health Policy and Clinical Practice.WehaveJonathan Gruber,aprofessor ofeconomics at MIT,and Meredith Rosenthal,an associateprofessor ofhealth economics and policy at the Harvard School of Public Health.
Why We Need Cost Control
So let me start with you, Professor Gruber. Is it actually that important that we reduce how much we spend on health care?
DR. JONATHAN GRUBER: In the long run, cost control is what it's all about, because ultimately the federal government will be bankrupted by the costs of medical care. Here's one simple example. Just to pay off what Medicare is going to owe under projected law with no changes, we'd have to raise the existing payroll tax rate which is 2, a little over 2%,to about 14%. And that's just — and that's under very conservative projections,actually.So if wewant to keep our fiscal system in order, we need to control the cost of health care.
DR. GAWANDE: Well, but if this is what it takes to save people's lives, if it's taking more of our economy, and this is what people want to spend their dollars on . . . . We're spending more and more dollars on little tiny electronic gadgets. Why not on health care?
DR. GRUBER: If you want to take that perspective, then we need to move to a system where voters and consumers understand that set of priorities. That means, for example, not including a bunch of subsidies towards health care that are sort of hidden in our tax system and in our spending system,but making clear to consumers what they're spending. If, in that situation, America decides that they vote 50% of GDP to health care, great. What's more important than your health? But we're in a situation today where Americans don't understand what they're devoting to it and don't understand that they're not really getting the value for their dollars.
DR. GAWANDE: Professor Rosenthal, do you agree that inflation of health care costs is this fundamental as Professor Gruber lays it out to be? And if so what are the kinds of options or strategies we have, if you do agree?
DR. MEREDITH ROSENTHAL: I think surely this is true. And I think aside from the public burden of increased Medicare and other government spending on health care, I think we have to recognize that the high and growing cost of health care also means that we can afford to cover fewer people and to subsidize less the health care for the low-income folks. Even if we do get universal coverage, there are going to be serious equity implications for high cost growth.
So I think looking at reforming the health care payment system would be number one on my list for ways to start approaching cost control. But I think more broadly, we need to have a more open societal dialogue, I think going back to what Jon said, about what our priorities are. And we have never in this country been comfortable talking about rationing explicitly. And I think there's a need for that dialogue informed by evidence.
DR. GAWANDE: So I'm interested that the first place you went to is the payment system, how I get paid as a surgeon. And that implies that our payment system, when we think about the runaway health care inflation problem, that the payment system is the root cause of it.
DR. ROSENTHAL: Well, of course it's complicated. The payment system interacts with things like norms and other aspects of the institutional nature of health care. But we have very good reason to believe that because we pay for units of service, for visits, for surgeries, for days in the hospital, that we get more of these things. And there's good evidence from experiments and natural experiments that show very significant changes in patterns of health care when payments change.
DR. ELLIOTT FISHER: I think it's a subconscious influence on the way many of us practice. And a lot of it is driven by the environment within which we practice. Hospitals are paid the same way, and hospitals need to balance their books, and often are recruiting more physicians who have — provide services that have higher margins that are more profitable, so that the hospitals can balance their books.
But I think the way it influences our practice is in very subtle ways. Medical care system currently, fee for service does not pay for us to have long conversations with our patients. When we're feeling constrained, as many of us are in the current system (price for an office visit isn't very much), it's much harder for us to have that long conversation with a patient with heart failure to see if we can safely manage them at home.
The default position in many communities becomes, "Gosh, I'm too busy. I better send them to the emergency room." The emergency room physician recognizes full well that they don't have time to manage the patient with heart failure in the emergency room, so admits them to the hospital. To the extent that those resources are available for us and we're not paid to do the things that we really would like to do or know we should do, we see huge differences in the likelihood of really unnecessary hospitalizations in different communities.
DR. GAWANDE: So if payment systems are one of the core things to address, how do you address it? What are the proposals that are actually out there being offered? And Jon, I think you're being asked to actually make cost estimates based on some of these proposals and what they're going to do.
DR. GRUBER: Okay, the right answer is, managed care 2.0 done smart. And by "done smart," what we mean is the following: a) smarter on the input side, which is, don't just pay a flat fee, pay in a risk-adjusted way based on what's wrong with the patients. And the second change is on the output side; don't just reimburse them flat out, but reimburse them based on the quality and the value of what they deliver. And put it together in what we call an accountable care organization, we know what to do.
The problem is, we're pretty far from legislative language. And there's not that, quite frankly, can be in a bill by October 15th or by November 15th or probably even in the next couple of years. My feeling is, as we look to this round of reform, the science of coverage has gotten so farpast thescienceof cost control that that's why I feel likethePresident,on one level, did a bit of disservice holding up cost control as such a key feature of this round of reform. Because quite frankly, we can't do yet what Elliott wants us to do. We know theoretically what to do.
What we need to do in this round is set the predicates, set the landscape so that that can happen. That means, I think importantly, setting up institutions to study comparative effectiveness so we can get that information in place, and importantly in my view, making consumers more cost-conscious so that they're more receptive.
Until we're willing to tell doctors and the patients they can't have everything they want, we can't control costs.
DR. FISHER: Boy, I think there's so much unnecessary care in the current system that right now we can give patients everything they need and would want if well informed. I'm absolutely convinced. I don't think patients want unnecessary hospital stays. I think they'd much rather stay home than go to the hospital when they have heart failure. And we as physicians would much rather be able to take care of them in ways that are safer for them. I think the payment system and a number of other things, our sort of cultural norms in many places, drive us to do unnecessary things.
DR. GAWANDE: There is no solution like, "Put everybody on salary. That'll solve the problem." We — first of all, we're not sure that works. But second of all, we don't know how to do it in a safe way. So what is a possible next step?
DR. ROSENTHAL: It's not just that we don't know what the end goal should absolutely look like. Even if we knew the global payment system, risk adjusted with quality incentives, at the end of the day that we'd like to see, we have a delivery system that can't operate under that payment system. We have a very fragmented delivery system. And obviously conversations about accountable care organizations is part of trying to knit that together. But there needs to be a transitional payment model that would be paired with a transition in the delivery system.
And I think most of the proposals along those lines involve bundled payment of one form or another. Bundling payment for readmissions with the primary admission is the smallest piece of that. But there are payment models like Prometheus payment that are looking to put together all the components of care for a clinically defined episode, and try to get various clusters of providers maybe acting as medical groups, maybe working together collaboratively to accept risk for those episodes. So I think that's the path towards a more global payment model.
DR. GAWANDE: Experimenting with these kinds of approaches makes perfect sense. Imposing it across the country as the way we're now going to pay everybody as of January 1, 2010, would cause havoc, because we're still figuring out if it even works for a single disease. And so, first of all, what are the provisions in health reform that can — that can push us down the path of trying these experiments?
DR. FISHER: I think the House legislation that we've seen so far and the drafts of the Senate legislation from the Senate Finance Committee that we saw earlier all include pretty aggressive pursuit of pilots on all of these dimensions, whether it's medical home payments for primary care, essentially bundling payments to support--strengthen primary care or accountable care organizations, or bundled payments and readmission payments.
A Public Insurance Option
DR. GAWANDE: But then there's all theseother possibleapproaches that people are suggesting.So onethat is very much on the table is the idea of a public option for insurance coverage.
DR. GRUBER: The important aspect of a public option is: will they regulate rates that are paid to providers within the public option, as is in the House legislation, for example? And that's, among sort of the thinking people in this fight, what the battle is about. The less important part is who owns the plan. Is it GovCare or Aetna? Well, the truth is, if they're paying competitive private rates, it doesn't really matter that much.
DR. GAWANDE: So does paying providers less change the cost of the system?
DR. ROSENTHAL: If the public option could come to the table with a reformed payment system, a radically different payment system, and perhaps not contract with every provider, allow certain accountable care organizations and others to come forward, it could perhaps innovate in a way that's just not possible based on the way health plans compete in our system now.
DR. FISHER: Although we don't necessarily need a public option to do it. We have, for the Medicare population — a large population that is very interested in some of these pilot — you know, in some of these new ways of paying.
DR. GRUBER: The problem is, politically, we've tried Medicare pilots and they get killed. But if this legislation could bring the hammer down, say, you know, "We are going to have these pilots even if local politicians don't want them. We are going to have these pilots," then that would be a very significant step forward. We have a goal we'd like to achieve, which is to bring our health care costs under control in a sensible way. That's a goal that we don't know how to achieve yet.
DR. GAWANDE: What about the argument, though, that we do know how, single payer? If we had a single-payer system, this would control our costs.
DR. ROSENTHAL: I mean, I think if you — if you just look at Medicare today and all you did was expand it to the rest ofthecitizenry,then we'd still befacing thesameproblems that we'refacing now.So I think,again,you need a — you need a shift in social decision making around health care. And I think there's been some conversation about creating an entity that would be somewhat politically insulated that could make and really implement decisions about reform — an entity with the legitimacy to guide the country towards making more reasonable tradeoffs in terms of--in terms of how much and--and what we want to spend our health care dollars on.
DR. FISHER: There are more optimistic visions of what a single payer might do, become an aggressive, you know, supporter of reorganized and improved care. That's a different vision of what a single payer might be like, one that I could be attracted by.
Consumer-Based Approaches
DR. GAWANDE: The other point of view is that we should really be heading in the direction of creating medical savings accounts where people have high-deductible health care coverage, and they have some skin in the game as--as the economists like to say.
DR. ROSENTHAL: Well, first and foremost, we have lots of evidence that when people pay out of pocket, they don't make terrific decisions about what to--what to seek and what not to seek. And second of all, because of the nature of insurance, we need to protect people against catastrophic risks, against high costs. This cost sharing would be limited to theend ofthedistribution ofhealth carespending that matters least.So what is driving high and growing health care spending in theU.S.is in thetail of the distribution,very high-cost interventions and very sick people.And cost sharing is totally inappropriate there.
DR. GRUBER: There's no one who thinks seriously about this that thinks that a consumer-based approach can control costs in afundamental way.I mean,ultimately,thesupply sideis whereit has to happen.Physicians make the decisions.
Hospitals make the decisions. Consumers can't shop from the back of an ambulance of where to get treatment for their heart attack.
That said, I think it's very important to recognize, to learn from the lesson of the managed care backlash. I think the fundamental lesson there is people didn't see the savings. We had 3 years where health care costs grew by--employersponsored premiums grew by 2% or less a year, which is amazing, below inflation for 3 years in the late '90s. But people don't know that. And unless you give people a financial stake in what's happening, there's going to be a backlash against accountable care organizations, just like there was against managed care.
Comparative-Effectiveness Research
DR. GAWANDE: There are a number of provisions that would--that would come into--as a part of health reform and make a difference in care. And you mentioned one early on, comparative effectiveness. Exactly how does someone doing research in Washington on whether one statin or another statin works, and having a result 5 years from now, how does that translate into savings? Or am I misunderstanding what comparative effectiveness really is?
DR. ROSENTHAL: I do think in general, we have a grave lack of head-to-head evidence on the effectiveness of clinical interventions. And without that information, commercial payers in particular, but also Medicare really lacks the ability to try to impose rules that might improve the value of health care spending.
DR. FISHER: As a clinician, it would be wonderful for us to understand better what the real risks and benefits of these treatments are so that we can help our patients make wiser choices. And that's the fundamental issue. You know, lung reduction surgery for chronic obstructive pulmonary disease, if it doesn't work, gosh, we really shouldn't be doing it.
So the other thing that's missing from the comparative effectiveness discussion is that we really need to be understanding the effectiveness of different delivery systems and different approaches to delivery. Because that's where the real opportunities for both improving care and reducing spending are.
DR. GRUBER: This is actually almost certainly a no-brainer. It's just impossible to argue that more information here wouldn't be good. And I think the notion that, gee, somehow making the information available will turn the government into Big Brother is just crazy within the context of our political system. Right now we are so far away from Big Brother, we are so hands-off, we do so little to really talk about what's effective, that we can only move in the right direction at this point.
DR. GAWANDE: I'm suspicious we won't have enough information in the next 5 or 10 years to actually make a significant dent in the system. We will always have to be making decisions in the gray zone, even with comparative effectiveness. I mean, can we claim billions and billions of dollars from the research that will come out of this?
DR. FISHER: I think it depends on--I agree with you. Judgment is essential. This information, especially Treatment A versus Treatment B, is not going to dramatically deflect the growth of health care spending.
DR. GAWANDE: Especially when it shows us that the 10-times-more-expensive Treatment A was better.
DR. FISHER: — was better, that would probably, could increase costs.
DR. GRUBER: Maybe you do learn that the 10-times-more-expensive Treatment A is better. Great. Then do Treatment A, as long as the public understands its costs, and we understand its effectiveness. Then super, then let's do that. The problem is, neither's true today. Both those need to be addressed. And it's never going to take out the huge share of decisions that are gray zone. But look — even a tiny, tiny effect on the growth rate is billions and billions of dollars over time.
DR. FISHER: Weseehugedifferences in growth rates across communities.So,you know,you haveSan Francisco,San Diego, central Pennsylvania, many other communities around the country, Tallahassee, Richmond, Virginia, where cost growth has been at least a percentage point below the national average. And no one in those communities is aware of rationing. None of the physicians in those communities would say, "We aren't providing the beneficial treatments." So the kinds of deflections that we need to achieve trillions of dollars of savings are relatively modest. And they're mostly going to come, I think, from reorganizing care delivery, not from eliminating beneficial and wanted care.
The Need for Reform
DR. GAWANDE: What do we need to see coming out this year and what might happen if we don't?
DR. GRUBER: I really think what we need to see coming out of this year is coverage. I think that even if this bill fails, I think cost control's a longer-run battle of which this is just a very small part. The critical part is about covering the uninsured Americans. It's our moral obligation to do so.
DR. ROSENTHAL: I think passing coverage may be critical in part because it's an opportunity to be giving with one hand and asking with the other. And so giving to the pharmaceutical industry, giving to the insurance industry, and asking for reform, for changes in the way these private entities, which have such an important role in our health care system, do business. And I think without having that authority, it's going to be hard for the federal government to--to begin us down the road of cost control. So I think it's a political balancing act, but I think that coverage creates an opportunity.
DR. FISHER: Well, I think it would be a tragedy to miss this opportunity to expand coverage, in part because it helps fix so many of the problems that Jon and Meredith have identified with the health insurance system. I think the cost issues, I agree, are a longer-term issue. But gosh, it'd be too bad to miss this opportunity to get our children covered.
DR. GAWANDE: Well, thank you for that important sum-up, bringing back how the coverage fits together with the costs. This is an important moment for the country, a vital debate. And costs have been in the center of it, in part because it is the question of whetherwecan afford that coveragefor everybody.So thank you.And thank you all from the New England Journal of Medicine.

redpajama_set_name: RedPajamaCommonCrawl


State tax credits are available for owner occupied and income producing properties that are listed individually on the National Register and Virginia Landmarks Register, or are located in, and contributing to, districts listed on those registers.
The state program awards a 25% tax credit for all hard costs and most soft costs related to the renovation of an eligible historic building. The three part application is reviewed by the Virginia Department of Historic Resources and/or National Park Service for its compliance with the Secretary of the Interior's Standards, which are philosophical guidelines for the treatment of historic buildings.


Luminous Flux is an incredibly intense first person experience that blends pulsing audio, strobe effects, optical illusions and puzzles as you explore a massive virtual art installation, solve puzzles and attempt to unlock the exit.
Nails is a browser based experience where you interact with 27 surreal animated scenes, often experimenting with movement of the human body.
Oceanarium is a beautiful and bizarre experience where you swim around and discover the secrets of a strange hand drawn underwater ecosystem.


Kevin and I took a trip to Portland, Oregon this weekend. (The second flying trip since being pregnant.) We also met friends, Kerri and Alex and explored the city together. The weather was not quite what we're used to, but we enjoyed eating out and being tourists.
Baby "M" did fine as well. We didn't have any problems when flying TO Portland, but when we returned Baby must've been exhausted. I ended up getting sick as soon as we landed into Phoenix.


And worse, you've been reported for spam.
So what are all the other successful email marketers doing that you're not? Are they smarter than you? Is there some secret tool everyone is keeping to themselves?
Here's the difference: You're "spraying & praying" by sending the same emails to your entire email list.
And this needs to end.


text:
<menu xmlns:android="http://schemas.android.com/apk/res/android"
    xmlns:app="http://schemas.android.com/apk/res-auto"
    xmlns:tools="http://schemas.android.com/tools"
    tools:context="com.adammcneilly.cashcaretaker.com.androidessence.cashcaretaker.main.MainActivity">

    <item
        android:id="@+id/action_transfer"
        android:icon="@drawable/ic_transfer_white_24dp"
        android:orderInCategory="1"
        android:title="@string/transfer"
        app:showAsAction="ifRoom" />

    <!--TODO: Re-add in v 2.1 -->
    <!--<item-->
    <!--android:id="@+id/action_settings"-->
    <!--android:orderInCategory="100"-->
    <!--android:title="@string/action_settings"-->
    <!--app:showAsAction="never" />-->
</menu>

redpajama_set_name: RedPajamaGithub


Indulgenced prayers and devotions are a git from the Church to aid us in our spiritual journey. A plenary indulgence is a full pardon for punishments owing for sin, sacramentally confessed, and makes possible immediate entrance into heaven after death. The requirements for gaining a plenary indulgence are sacramental confession, Communion and prayers for the Pope's intentions such as an Our Father and a Hail Mary. We must also have an attitude of love and penance, with no attachment to any sin. If this disposition is in any way less than complete, or if the three prescribed conditions are not fulfilled, the indulgence is only partial. This form of indulgence may only be gained once a day, and may be offered only for the deceased or for yourself. Prayers with this privilege are indicated thus ** in this book.
A partial indulgence is a partial pardon for penance owing. The faithful should at least have a contrite heart to gain the partial indulgence. Prayers with this privilege are indicated thus *. The Enchiridion of indulgences has been followed for these marked prayers. Older prayers are labeled thus, "indulgenced by Pope (Name)."
Scripture says, "Pray without ceasing." Saint Lawrence Justinian puts prayer in the proper light. He writes, "In prayer the soul cleanses itself from sin, charity is nourished, faith is strengthened, hope is made secure, the spirit rejoices, the soul grows tender, the heart is purified, truth discovers itself, temptation is overcome, sadness takes to flight, the senses are renewed, failing virtue is made good, tepidity disappears, the rust of sin is rubbed away. In it are brought forth flashes of heavenly desire, and in these fires the flame of divine love burns up." May the Pieta Prayer Book serve all souls who desire to advance their spiritual life and live in union with God.


text:
package com.google.android.gms.appdatasearch;

import org.microg.safeparcel.AutoSafeParcelable;

public class PIMEUpdate extends AutoSafeParcelable {

    public static final Creator<PIMEUpdate> CREATOR = new AutoCreator<PIMEUpdate>(PIMEUpdate.class);
}


text:
Staff and trustees
Funding and finance
Community programming
Global policy and advocacy
Conflict and gender sensitivity
South and South East Asia
Policy centres
People's security and justice
Gender, peace and security
Global action against conflict
Peacebuilding responses to terrorism and migration
Effective arms control
People and power structures
Supporting young people
Keeping girls' education high on the agenda in Kyrgyzstan
Women and girls in southern Kyrgyzstan fight against prohibitive gender norms that prevent them from going to school. We spoke to Nishanova Dilnoza, a 20-year-old student in Yrys, to find out more about girls' education in the region and what she is doing to help the women in her community.
In some conservative communities in southern Kyrgyzstan, girls regularly finish their education as early as 15 years of age. Yrys ayil okmotu is one of these communities in the Jalalabad region, where girls often drop out of school due to a variety of both deep-rooted and contextual factors such as prejudice, gender norms, corruption, religion, traditions or even a lack of information about tuition-free state education programmes. Gender norms in these communities, linked to local traditional and religious norms, often view women as belonging to the families into which they marry. Therefore parents are usually less interested in investing in their daughters' education. As a result of staying home, these women can also feel isolated and may have no way to find out about education programmes or other benefits of schooling.
"Most of my female classmates were forbidden to continue their higher education in universities," said Nishanova. "This is because their parents decided that they should stay at home, get married and learn how to manage the household. Restricting higher education for girls and women is often linked to early marriages and is a widespread problem in Yrys, like in most conservative or religious communities nowadays."
Nishanova is a 'Youth Ambassador' with whom Saferworld and local partners Foundation for Tolerance International (FTI) and Liberal Youth Alliance (LYA) have been working in the region. This work has involved training and increasing the capacity of these ambassadors to identify security concerns in the community and come up with solutions to address them. In their assessments, early marriages were identified as a priority concern, as the ambassadors felt they were linked to a lack of higher education in women and girls as well as other security concerns that might affect girls, such as domestic violence. They found that girls were often forced into marriage at a young age because parents believed that investing in their education would be a waste of time and money due to a lack of opportunities for work. Husbands were often seen as the best alternative to provide for their daughters, and so early marriages were arranged.
Nishanova said that the project has helped to raise awareness of the importance of girls' education. "The aim of the initiative was to explain to parents the importance of women's education. We organised information-motivation meetings about the benefits of higher education for girls, with prominent women leaders in three locations, and arranged two excursion tours both for parents and youth to universities located in Jalalabad. These were meant to be informative sessions outlining available tuition-free state education programmes and social benefits in universities. We also invited religious leaders to clarify to the parents that Islam does not forbid women's education."
The results have been positive. Before, many parents perceived universities to be corrupt institutions that would require heavy bribes for entrance. As a result they would prioritise their sons rather than daughters when working with a limited family budget. However, Nishanova said that many of the parents changed their minds after they heard from the female leaders. Some of them even allowed their daughters to take the university entrance exams after learning about tuition-free state education programmes on their excursions.
Parents went on tours of universities as part of the awareness raising project
"Working on this has made me feel really good, because we had kept silent on these issues for many years. I feel strong and confident enough to speak up about security issues facing women in my community and challenge gender and social norms. Security issues affecting women are a key part of the entire community security approach, because gender-sensitive strategies make the process inclusive and respond to security needs of everyone involved. I was leading a team of both men and women for this campaign, and I realised that the men also considered me to be a leader."
Nishanova said that in the beginning she was worried about being misunderstood by the community when leading such a sensitive campaign. "But later I persuaded myself that it is always important to develop, to grow and to do the right thing. There is no need to give way only because you are afraid that people will judge you."
Saferworld's "Youth Ambassadors" project in Central Asia covers 24 communities in the south of Kyrgyzstan. The primary goal of the project is to promote youth leadership and inter-ethnic collaboration on security provision in Southern Kyrgyzstan. The project supports youth to move away from heated ethnic discourse by helping to develop ethnically diverse grass-roots activists into leaders, and supporting constructive cooperation between them, their communities and security providers. The main focus of this cooperation is on mutual security challenges and promoting inclusive policies and practices.
Find out more about our work in Central Asia.
Header image: Dilnoza presenting her project at a conference
Get the latest news, publications comments and analysis from Saferworld
Receive our email newsletters
© Saferworld 28 Charles Square, London N1 6HT, UK Tel: +44 (0) 20 7324 4646 Email: general@saferworld.org.uk
Registered Charity No. 1043843 Company No. 3015948 | Privacy & Cookies | Terms & Conditions
Website designed and built by Adept
Open information
Conflict sensitive humanitarian action
Human rights, safety and security
Somalia/Somaliland
Governance and peacebuilding
Research and policy
Amplifying young voices
Land governance
Building safer communities
Empowering young people
Youth, peace and security
Strengthening civil society
Syria and the Levant
Businesses for peace
Governance, security and peacebuilding
Conflict-sensitive development
The Arms Trade Treaty
Alternative approaches to counter-terrorism
Addressing the causes of forced migration
Africa-China-EU Project on arms
By continuing to browse the site you are agreeing to our use of cookies. ContinueFind out more


text:
Bela Crkva kan syfta på:

Nordmakedonien

 Bela Crkva, Nordmakedonien, ort,

Serbien

 Bela Crkva (kommunhuvudort), Vojvodina, Južnobanatski Okrug,
 Bela Crkva (ort i Serbien, lat 44,40, long 19,48),

redpajama_set_name: RedPajamaWikipedia


text:
Stara Uszyca (ukr. Стара Ушиця, Stara Uszycia) – osiedle typu miejskiego na Ukrainie, w obwodzie chmielnickim, w rejonie kamienieckim. W 2001 roku liczyło ok. 2,5 tys. mieszkańców.

Miejscowość leży na terytorium Parku Narodowego "Podolskie Tołtry", niedaleko ujścia rzeki Uszycy do Dniestru.

W miejscowości znajduje się sanatorium dziecięce "Dnister".

Niedaleko (koło wsi Bakota) znajduje się monaster św. Michała Archanioła (XII-XIV ww.), wycięty w skale wapiennej.

Historia
Miejscowość pochodzi przynajmniej z XII wieku. Pierwsza wzmianka o Uszycy pochodzi z ruskiego latopisu z 1144 roku, kiedy Izasław Dawidowicz zagarnął w swoje posiadanie miejscowość, która należała podówczas do księcia halickiego Włodzimierza. W 1240 roku została spustoszona przez Tatarów. Po przyłączeniu do Polski należała do dóbr koronnych. Po II rozbiorze Polski znalazła się w granicach Rosji. W 1795 roku otrzymała status miasta powiatowego namiestnictwa podolskiego. W 1796 roku nadano miastu herb. W 1826 roku siedzibę powiatu przeniesiono do Letniowców przemianowanych na Nową Uszycę, wobe czego Uszyca otrzymała wówczas nazwę Stara Uszyca. Do 1917 roku znajdowała się tu rezydencja rosyjskiego rodu szlacheckiego Gagarinów. Jedna z księżniczek opublikowała na emigracji swoje wspomnienia zawierające opis okolic Uszycy. Pierwsza droga bita do Kamieńca została zbudowana dopiero w 1914 roku przez armię austriacką. W 1979 roku miejscowość otrzymała status osiedla typu miejskiego. Po budowie sztucznego jeziora na Dniestrze w latach 80. XX wieku Stara Uszyca została zatopiona wraz z cerkwią i cmentarzem, a mieszkańców przeniesiono do nowo wybudowanego osiedla na wzgórzu, kilkaset metrów na północny zachód od zatopionej miejscowości.

Przypisy

Osiedla typu miejskiego w obwodzie chmielnickim
Dawne miasta na Ukrainie


So I started playing with the VR edit mode now that I have a Oculus Rift, and using certain objects makes the whole display in the HMD go black. Running the VR with hand controls template and if I go into say Landscape editing mode everything turns black and I have to exit back to Oculus home, bring up the desktop, exit VR mode and then go back in to get it to come back. Any ideas? It's not everything doing it like I said, just certain options.
How do widgets work in VR?


Bandcamp Track of the Day: Lorelle Meets the Obsolete || These Days.
Track Spotlight: [aftersun] || When Mama Was Moth (Cocteau Twins cover).
Bandcamp Track of the Day: Ceremony || Send Me Your Dreams.
WTSH Classic Trax Archive: A.R. Kane. Suicide Kiss.
Video Spotlight: broaddaylight || Three Light Six (2013 Lighter Mix).
Video by broaddaylight and Wyatt Parkins.
Saint Marie Records compilation Static Waves 2.
News: Free Stream of The Fauns' New LP Lights.
Lights, the sophomore full-length by Bristol's blissful shoegazers The Fauns, can be streamed on Bandcamp, where the album's digital edition is now available for purchase. CD and vinyl will be out from Invada Records on December 2nd.
TONIGHT! WTSH on Strangeways Radio. Stream it live 10pm EST / 9pm CST.
New Cassette Release: White Blush || White Blush EP || Limited Edition 100 copies.
Available from Rok Lok Records & limited to a gorgeous edition of 100 pro-dubbed, white clam shell cassettes packaged in white/clear norelco cases with full color card stock covers. White Blush is Carol Rhyu (read WTSH's interview with Carol HERE).
When The Sun Hits Top 5 Albums of the Week.
Video: Dark Bells || Want.
Video Spotlight: The Fauns || Lights.
New Single: The Casket Girls || Same Side.


Yes, travel will do that to you.
Most recently, it was the Iberico Ham in Spain.
We ate it every day. We ate it in the pool. We ate it in restaurants. The supermarket (never mind the heavenly La Boqueria market in Barcelona, or Fairway, I'm talking about Stop and Shop type places), had Jamon Iberico corners. The airports have Iberico ham restaurants the way we have Jamba Juice stores.
For the uninitiated, the source of this treat is a black Iberian pig, either pure bred or a minimum 75% pure. The quality of the ham depends on the breed, the amount of corn and acorns and feed at the end, for lesser types, and the 12 to 48 months aging, again a quality factor. Sliced super thin, it bursts with flavor, the best with just enough chew and just enough fat.
I've never met a slice of Jamon Iberico I didn't like.
Then there was the trip to Tokyo with the daily (at least) toro. And the regular pilgrimages to Berthillon in Paris. Note to self: It may be time for another quality control check on the sorbets.
The trials we travelers face!
It's all making me way too hungry!! Love the blog — keep it coming.


text:
Q: Yii CMenu active item sometimes sets, sometimes not I have problems to set CMenu active item, sometimes it works, sometimes not.
For my CMenu, "items" array format is:
array('label'=>'LED piedāvājumu izstrāde ', 'url'=>array('/customPages/view/id/3', '/rating/index'),'itemOptions'=>array('class'=>'dropdown','tabindex'=>"-1"),'linkOptions'=>array('encode'=>false, 'style'=>"width:110px;",'class'=>'dropdown-toggle','data-toggle'=>"dropdown","data-description"=>""),
                    'items'=>array(
                        array('label'=>'Gaismekļu piemeklēšana', 'url'=>array('/customPages/view/id/3')),
                        array('label'=>'rating', 'url'=>array('/rating/index')),
                    )

Item is active /rating/index, but not active when link is like /customPages/view/id/3
Maybe problem is because of link formatting because in main.php in urlManager I have a rule 'Gaismeklu_piemeklesana' => 'customPages/view/id/3',
Someone knows how to fix this issue?
Thanks!

redpajama_set_name: RedPajamaStackExchange


As a business owner you always need to have customers' needs in mind. Usually chief among those needs is safety and privacy. You can't provide a charging kiosk if it's dangerous, or could compromise the security of their phone. For more information about the safety of charging kiosks, check out a recent blog post from Veloxity.


text:
Home » International Report
International Report
Siemens to Supply Swiss Voice and Data Radio Network
German contractor Siemens AG's Information and Communication Networks Group has been awarded a contract valued at approximately DM50 M to supply, install and commission a new secure voice and data radio network for the Swiss customs service. Under the terms of the contract, Siemens is expected to fully implement the network by the second half of 2001 and supply a system based on the company's Tetrapol technology. Tetrapol is a digital trunked radio system that has been specifically designed for use by organisations such as police forces, fire and rescue services, customs and border patrol authorities, and the military. The system has a modular architecture that allows networks to be tailored to specific geographical requirements and utilises a 12.5 kHz bandwidth to facilitate integration with current analogue frequency bands. The specified bandwidth characteristics allow soft migration between analogue and digital applications. Other features of the system include automatic mobility management, end-to-end encryption of voice and data, direct communication between system terminals without the need for base stations and the use of frequency division multiple access technology to facilitate wide area coverage. Once in service, the new system is expected to operate within a 30 km border protection strip around Switzerland for use in internal communications as well as cross-border links with the border patrol and customs services of Switzerland's neighbours.
Turkey Selects UK Radio Communications System for New Airport
UK contractor Park Air Electronics Ltd. (PAE) has been selected by Turkey to supply a comprehensive ground-to-air radio communications system for use at the new Sabiha Gokcen International Airport, which is currently under construction near Istanbul. The system comprises fixed and mobile VHF (approximately 30 to 300 MHz) transmitters and receivers (including man-packs and vehicular installations) together with a fixed-site UHF (approximately 300 MHz to 1 GHz) subsystem with which to communicate with military aircraft. The primary system equipment is drawn from the company's 5000M series transmitters and receivers that operate in the 118 to 137 MHz and 225 to 400 MHz frequency bands, respectively. Other features include auto tracking filters, 8.33 kHz channel spacing, built-in test (including integral test oscillators and analogue/digital converters) and a serial data link interface with the company's multi-access remote control system. The mobile/portable VHF system element is met by technology based on the company's model 5610 transceiver. Operating in the 118 to 137 MHz frequency range, this 7 W equipment has provision for the installation of both VHF and UHF antennas and incorporates backup DC batteries in the case of a primary AC source failure.
Philips Develops New SOC Design Methodology
Netherlands contractor Philips Semiconductors Inc. has developed a new system-on-chip (SOC) design methodology under the designated silicon system platform (SSP) concept. SSP incorporates a re-usable module approach for hardware and software intellectual property blocks along with a given application area architecture that provides rules to ensure that all elements of the device fit together correctly. To maximise usability, a number of SSPs have been created for applications that have similar functional requirements. Each SSP has an open, programmable architecture and a kit of re-usable hardware and software components (including application driver code) that provide all the elements necessary to create an appropriate IC solution. The architecture of each SSP defines the rules for module interface design and provides scalability within each platform's domain by its ability to mix and match appropriate hardware and software components. Core re-usable components identified by Philips for use in the SSP include memories, analogue and digital blocks, digital signal processors and design support tools. Specific components cited include the company's eight-bit 80C51 and 16-bit XA microcontrollers and TriMedia™ processor cores that can be used in multiprocessor environments; reliable and re-usable SSP software components, including drivers and application-specific components that are in a direct analogy with the architecture's hardware components, are also being offered. Most significantly, SSPs will not become obsolete since they are reprogrammable and can be enhanced by the introduction of software upgrades. The described platform is expected to substantially shorten design and development times from months to weeks and produce ICs that typically work the first time.
UK SIFF Programme Outlined
In response to the collapse of the North Atlantic Treaty Organisation's (NATO) effort to develop an alliance-wide next-generation identification friend-or-foe (IFF) system, the UK has launched the Successor IFF (SIFF) programme to completely upgrade the country's tri-service IFF systems capability. As set out in the UK Staff Requirement (Sea/Land/Air) 924, the SIFF effort intends to upgrade the current tri-service IFF Mk Xa provision to the Mk XII standard (which will include Mode 4 functionality), introduce the Mode S IFF transponder function and provide a risk-free growth path to the Mode 5 encrypted waveform standard. SIFF involves 51 platform types and will eventually see upgraded capabilities installed on 984 aircraft, 87 ships and submarines, and 452 ground-based systems.
In an attempt to balance numbers and platform availability issues, the SIFF programme comprises three implementation processes. In Approach A, a prime contractor will be selected to provide the necessary equipment; manage its installation, integration and service acceptance; and provide through life logistic support. In Approach B, the particular platform's design authority will manage the installation, integration and service acceptance of SIFF-compatible IFF interrogators with a selected subcontractor supplying the necessary hardware and through life support. In Approach C, the individual design authorities will manage the installation, integration and service acceptance of SIFF equipment. An interrogator suited only for the Improved UK Air Defence Ground Environment is included in Approach C with equipment supply being directed by the UK's Ministry of Defence. Logistic support for Approach C installations will be leveraged from the Approach A structure. The 10-month SIFF integration and planning study contracts were awarded in 1997 with full-scale development and initial production of equipment scheduled for early 2000.
The acceptance of Approach A is described as a make-or-break award that will leave the selected contractor as the UK's only viable IFF system manufacturer. As of press time, identified competitors for the SIFF Approach A award included the Marconi Avionics Group (MAG) consortium (comprising MAG (acting as prime, platform-system integrator, man-machine interface provider and equipment installation), Marconi Aerospace Systems (shipboard/ground interrogators, cryptography and module repair) and Thomson CSF Communications (airborne transponders, cryptography and module repair)) and UK-based Raytheon Systems Company Ltd. Both competitors have already won or have been selected for elements of the SIFF programme.
MAG has been selected to provide the SIFF Approach B package for the RN's Sea Harrier FA.2; Raytheon has been selected to pick up the Approach B provision for the BA/RAF Rapier surface-to-air missiles (SAM) together with that for the RAF's Tornado F.3 interceptor. In the case of the Sea Harrier effort, MAG will install the AN/APX-113 combined interrogator/transponder while the Tornado F.3 fit comprises Raytheon's IFF 4500 interrogator, IFF 4810 transponder and IFF 4870 control box. The Rapier SAM installation is an upgrade of the existing equipment fitted to the weapon system.


World-renowned cigar producer A.J. Fernandez makes Diesel Cigars. Fernandez is a young producer who has cut his teeth in the industry producing great cigars for other brands such as Rocky Patel.
5 Vegas AAA, Ave Maria, Emilio AF-1, Emilio AF-2, Est. 1844 Anejado, Graycliff G2 Turbo, Gurkha Park Avenue, La Herencia Cubana, La Herencia Cubana Core, La Herencia Cubana, Oscuro Fuerte, La Cuna Bin No 85, Morro Castle, Padilla Habano, San Lotano, San Lotano Oval, San Miguel, and Sol Cubano Cuban Cabinet among others. Diesel Cigars is a line Fernandez began producing in 2009 at his factory in Esteli, Nicaragua.
Copan, and has a Nicaraguan and Mexican fill. The Unlimited is a full bodied cigar from Diesel Cigars. It boasts a great balance of heft and spice, with sweet, leathery and sometimes oaky tones throughout. You can get your hands on this stick for around $4 or about $70 for a box of 20.
The Shorty is a 4.5″x60 Diesel Cigar wrapped in a Connecticut Broadleaf with Nicaraguan filler and binder. It was created by Fernandez in honor of Shorty Rossi the reality TV mogul. This robusto offers a full body and is a substantial smoke. This stout Diesel Cigar exhibits rich and smooth chocolaty tones combined with the poignant and flavorful espresso notes. At around $5 a smoke or $90 for a box of 24, this is a powerful cigar you won't soon forget.
The Unholy Cocktail is a 5×56 Torpedo (belicoso), which is wrapped in a dark brown Pennsylvania Broadleaf, filled with a: Nicaraguan blend comprised of Jalapa, Condega, and Esteli grown tobacco all of which has been aged for three years. The Unholy Cocktail is lighter than the Unlimited but still brings a strong balanced flavor. This may be Diesel Cigars' most flavorful cigar. It hits on notes of wood, wild berries, and nuts. A single will run you about $5 and a box of 30 will be around $100.


text:
Home » Regions » South » Texas » Rio Grande Valley » A Food Revolution in Rio Grande Valley
A Food Revolution in Rio Grande Valley
A food revolution is on the rise in the Rio Grande Valley as more and more cities host farmers' markets featuring locally grown produce, ranch meats, farm eggs, honey and other items. The food available at these outdoor markets is as varied as its growers.
Barefoot, tending immaculate rows of squash, cucumber, tomatoes and field greens, Susanne French seems a fraction of her age. The food she grows with her husband, Bud, at Acacia Farms near Bayview surpasses government specifications for organic products. Besides their sun-up to sun-down weed pulling, planting, watering and harvesting, the couple tend a compost pile that's treated with as much care as their crops. The couple mixes organic molasses and other organic additives into a towering heap of decayed plants and organic matter to maximize the nutrients that will soon fertilize their gardens.
Though most local growers that sell at farmers' markets don't use chemicals or pesticides, Acacia Farms takes the extra step to create homegrown, organically produced compost, a technique that was central to the farms that created the organic movement decades ago.
In the last few years, the U.S.D.A. has relaxed requirements for farms to receive organic certification, so chemicals and pesticides can be used by farms and still receive "organic" certification. But some, like Acacia Farms, are carrying the torch of commitment and dedication to people and the environment that was the original catalyst for the organic farming movement by not lowering their standards. In addition to continuing to grow true organic crops, Acacia Farms also donates some of their crops to organizations that feed the hungry.
French, who has a degree in organic chemistry, spent 15 years running a plant nursery prior to starting the farm. Acacia Farms is one of the larger farms featured at Valley farmers' markets. Others simply share harvests from their own gardens. Still, other vendors offer homemade crafts, jewelry, clothing, soap, bath salts and more.
Ruth Wagner does both. A retired teacher and community activist, Ruth sells fruit, herbs and vegetables grown in her West Brownsville garden, along with aprons, oven mitts and other kitchen apparel.
The first farmers' markets four years ago were launched by university programs to encourage access to fresh fruits and veggies in unhealthy areas, while promoting small-scale, pesticide-free farming. Thousands of vouchers that could be redeemed for farmers' market food in zones with high rates of diabetes and heart disease were distributed. The fresh-food-for-vouchers program was meant to encourage healthy eating, but with such high-quality food to be found, others soon discovered the markets – from home cooks to chefs looking for the best-tasting products. Amid the rise of farmers' markets, the Texas Food Revolution was born, a team of volunteer chefs and home cooks who promote the benefits of local produce through public demonstrations and cooking lessons.
Introducing simple recipes using local ingredients is central to the Texas Food Revolution's approach. Without them, shoppers might be intimidated by food with which they are unfamiliar. Some of the recipes used in demonstrations include winter melon, luffa squash (also known as Chinese okra or silk squash), cactus and other unique market offerings as main ingredients.
Some of the featured recipe demonstrations have included grapefruit pies, omelets, carrot-top pesto and South Texas Calzones (featuring ranch sausage, local cheese and a wheat tortilla produced in Weslaco).
"Our recipes happen instinctively because it makes sense to use local, fresher ingredients rather than those that have to be transported here," said Joe Boswell, a Captain with the Texas Food Revolution and outreach director for the Rio Bravo Wildlife Institute. "This is about simple food; real food."
Members of the Texas Food Revolution are called "Captain" to illustrate that each is in charge of his or her own voyage in the realm of promoting local food.
Although not a chef, Boswell introduced an all-vegetable sushi roll at the Brownsville Farmers' Market two years ago. Since then, the Texas Food Revolution has sampled out more than 300 vegetable sushi rolls at farmers' markets, public events, home dinner parties and more.
"The recipe varies but can include any vegetable that you can find at a farmers' market and eat raw, as well as the local cheese, honey, jams, nuts and other market ingredients," said Boswell. "Roll them up in a seaweed wrapper and dip them in soy sauce and you've got a super delicious treat that also supports the small farm economy."
By purchasing local food from local pesticide-free growers, shoppers can help reduce carbon emissions into the environment, reduce chemical runoff from farms and support a local farm and ranch economy, noted Captain J.R. Garza, a local food critic who has written for various independent newspapers and blogs.
"The Texas Food Revolution is like a renegade economic development corporation that's dedicated to the aspect of local food production, " said Garza. "Mainly, though, we are concerned with reducing pesticides in our food and reducing the distance that food travels from the farm to your fork."
That the small farm industry has benefited from the Texas Food Revolution is clear. The Farmers' Market at Weslaco, for example, started with two core farms that produced the majority of the market's food. Now there are more than five farms featured, with several other small farms selling during their harvest time.
Bertha Alaniz is one of the farmers whose profitability has improved by selling her food at farmers' markets. She credits her participation with a reduction in chemicals and pesticide used at her Rio Hondo farm.
She and her husband, Pedro, tend to hundreds of acres, growing cabbage, onions and other large-scale crops year-round for commercial distribution. In the past, they used traditional chemical farming techniques. But since the couple began selling food at farmers' markets more than three years ago, they've reduced pesticide use in their industrial production and have reserved several acres for pesticide-free farming, where they grow food specifically to sell at farmers' markets.
"We understand that farmers' market shoppers want to avoid pesticides and chemicals in their food," said Alaniz, in Spanish. "So we're changing how we grow food so that shoppers will have confidence in our product."
Things to Do in Rio Grande Valley
Things to Do in Rio Grande Valley TX Basilica of Our Lady of San Juan Del ...
Welcome to Rio Grande Valley
Welcome to Rio Grande Valley From the white sand beaches of South Padre Island to the gently ...
TBD ALAMO – Photography walks at Santa Ana National Wildlife Refuge. Bring your camera and ...
Where is Rio Grande Valley
Where is Rio Grande Valley The Rio Grande Valley is a warm and welcoming place where ...
Rio Grande Valley Calendar of Events
Rio Grande Valley Calendar of Events January Texas Citrus Fiesta in Mission features the coronation of Queen ...
World Birding Center Sites in South Texas
World Birding Center Sites in South Texas Bentsen-Rio Grande Valley State Park Features include an exhibit ...


text:
Method Acting Procedures
Relaxation For Actors
Sense Memory For Actors
Concentration For Actors
Magic If For Actors
Objects For Actors
Substitution For Actors
Animal Exercise For Actors
Song And Dance For Actors
Private Moment For Actors
Speaking Out For Actors
Moment-To-Moment For Actors
Justification For Actors
Affective Memory For Actors
Given Circumstances For Actors
Getting Started In Acting
The Pro Actor
Actor Agents
Actor Confidence
Actor Managers
Actor Unions
Actor Auditions
Actor Callbacks
Actor Day Jobs
The Actors Studio
The Actors Studio – History
Lee Strasberg On The Actors Studio Part 1
Lee Strasberg On The Actors Studio – Part 2
Lee Strasberg On The Actors Studio-Part 3
The Actors Studio Sessions
TheatrGROUP Interviews
Shelley Winters Interview-Part 1
Ray Walston Interview-Part 1
Barry Primus Interview-Part 1
Adrien Brody Interview
Stuart Stone Interview
Method Acting Proedures / Get Started Acting
Cast of "12 Angry Jurors" at TheatrGROUP
Presented By TheatrGROUP
"and so on..." Another TheatrGROUP Original
Psychiatrist's Wake from "And So On..." at TheatrGROUP
"and so on..." at TheatrGROUP
Camille, Kim & Kris at Their Psychiatrist's Wake
Rehearsal of Original "And So On..." at TheatrGROUP
Just Before A Fight At The Psychiatrist's Wake
Home » Lee Strasberg On The Actors Studio-Part 4
For that, often, we don't give you things and say, "If you do this, it'll get you where you want to go." We say, "No, if you do this, you will find where you want to go." And that's why, when we see, for instance, something like, in the last session, with the actress starting with certain ideas, then we see how those ideas may be very sound… I have nothing against them… but they do not help her to achieve the results.
She says she uses a "private moment" [exercise], but she doesn't really quite do it. We then say, "Fine. Don't worry about your interpretation. Use the private moment, see where it will carry you. And we then find that suddenly it carries her into doing the scene in a way that's so original. I don't care whether it's the right way for the moment, but that she finds such new ways of doing the things… ways which I couldn't perceive, she couldn't perceive, I don't know that anybody here could perceive.
And that's found not by knowing in advance that that's what I'm looking for, but only by subjecting oneself to some of the procedures that exist in our "method", so to say, in our work. And as a result of that, arriving at conclusions, this is what makes the work exciting.
Your comments, then, should be two-fold. First of all, there are times literally when I want an honest reaction and no more. When I don't want a technical reaction. I don't have to wait for your technical reaction for me to have a technical reaction. So, frankly, that is not, most of the time… there are times, by the way, when people observe things and draw them to my attention, so don't think that I can't be faulted, or there are not things that you can see that I've missed… there are… but that's not the basic thing that your presence is for.
There are times, for instance, as, in some of the last two sessions, when I want the people just to have an honest reaction, and I want them to be able to say, "I didn't believe a word that was going on, I don't know why. I'm not going to tell you how to do it. I'm not an expert. I'm looking forward to seeing what people have to say. All I know is, I didn't quite believe."
Because I want the people on the stage often to know that what I will tell them is not a solitary opinion, but that other people share the same thing.
When then, however, the people then comment and tell the actor that what he did was wonderful, and so on and so forth, then we really have a problem. The problem is not with the actor, the problem is with you. It's your willingness to accept a certain kind of acting as being good acting. And if it is, then obviously we need neither the Actors Studio nor your presence, because, frankly then, there's nothing much to be gained either way if that is the standard that is to be accepted.
We can ask the question, "How come, if I believe that this acting is bad, and there's better acting, and so on, how come the audience is satisfied with the bad acting that exists?" And the answer is, "The audience is satisfied with anything that comes up to the level that it is accustomed to. If all the pears that you see are green pears, those are the pairs that are going to be good pears. You're not going to know anything else. In fact, when somebody brings you a good pear, you're for a moment going to be a little shocked, a little startled. Maybe when you taste it, you say, 'Oh, this is different. Yes, I think it is good.'"
In other words, the standards are set not by what we know, because we don't know… the standards are set by what is in our environment. In acting, therefore, people are accustomed to what they see. And therefore, the standard that is set for us, the standard for achievement is what we see achieved around us. That is not what the Actors Studio accepts. The Actors Studio accepts the standard of the highest level of what acting is capable of, and of what the actor's talent is capable of… of the possibilities that are inherent in the scene, of the investigation necessary for that, and so on.
So that the comments that we ask from you are frankly not comments to tell your fellow actors what they should do. Why should they take your word for it when you yourself have just as much difficulty in doing it? One person says one thing, another person says another thing… who are you going to believe?
So that in this area, the sharing of the comment is more for seeing are you right in your observation, are you seeing the right thing, are you sharing with the actor on the stage experience that you've had, not, "I'll tell you what to do," but, "I don't know what to do, but I remember, I had this problem, in fact, I never solved it. What would be the solution?" That kind of contribution is always sound, no matter how wrong it is. Because it is always real, it is always personal.
Too much of your comments tend to be comments of, "I will tell you what to do." And then what happens is that creates on the one hand a false and erroneous idea of what is actually the reality. To give an honest reaction, to say, "I could not follow what you were doing", fine. But then don't say, "I couldn't follow because you didn't do this or your didn't do that", as if you knew, and therefore if he does it, it would work out.
So, I felt that I wanted to take this time, instead of cancelling the session, really to share with you some of this, because otherwise sometimes my comments are abrupt, or you raise your hand and I kind of look away, and then, especially the observers here, become very annoyed, when their opinion is not respected, to the extent that I sometimes have to say quite simply, "You are not here to tell us something. You are here so that we should tell you something. And if you don't feel that we should, then I don't know what you're doing here. You didn't come into the Actors Studio to teach. You came into the Actors Studio to learn."
Now sometime, we like to treat people to a certain extent as equal people, you see. When I am asking for a reaction and an observer raises his hand, I will let him because he's an individual, he's a human being, he's an audience, and I want to get an audience reaction at that time and therefore will permit it.
Sometimes, for instance, when we are technically involved I won't let observers because I don't know that they know the technical things that we are involved with. So therefore, I will look for help, or aid or participation from the members, only because I know that they know what we're talking about. They may be wrong, but they have a right to be wrong, if you know what I mean.
But with the observer, I don't know what his technical knowledge is, and therefore I don't know what he will suddenly, you know… start to say here, which has no relation to what we're concerned with, and which will only throw an individual.
Our standards are at a high, by which I mean they are standards by which we ourselves don't come up to. Within the Actors Studio, the people that represent the highest in the Actors Studio, are often most severely criticized. And people who have not yet attained that "star thing", and so on, do work here and we say, "That's the kind of work, that's what it is, these are the procedures, these are the things that we would like other people to use", so that we do not differentiate in terms of external achievment or professional achievement, though on the other hand, we do not disrespect professional achievement wherever that comes from. But, professional achievement is not yet a reason for being in the Actors Studio. There are people who are professionally very capable, yet frankly who would have great difficulty coming in as member of the Studio, only because we don't see what further things they're capable of. So we are very happy that they feel that they would gain some stimulus from their presence in the Studio, but if they wanted to become members, we might have to turn them down. Not because they're bad, but because we do not see… anybody that comes into the Studio comes in for the possibilities, never for what has been achieved.
If what has been achieved is what they came for, then they don't need the Actors Studio, obviously they've already achieved it, what more can the Actors Studio give them?
So the Actors Studio can only give them something if there is something more yet that they have not yet achieved. Where we see that, naturally there's a reason for membership. Where we don't see that, we often have great difficulty, because people then are puzzled: "Took in somebody else? Well she's not as good as I am", and they're completely right. And it's a very difficult thing to explain, because at a certain point we can't explain it. Since, if somebody comes in, we may find that we are wrong, that that individual has things, but they may not be obvious.
I know many people have come into the [Strasberg] Institute, for instance, and whose work blossoms and develops. But we do not in advance know where it will go, until they start to do the work. And the same thing might be true here, but these are some of the problems that we face.
This is actually the basic thing that I wanted to share with you, so that you should realize that often my temperament or my annoyance doesn't come from any one thing. It comes from a very basic thing, which I feel the Actors Studio does stand for, and must continue to stand for. And when it doesn't stand for that, frankly there's no reason for it. It's not a place just to come, and to enjoy yourself, and so on and so forth, and see other people. And that's a little bit what the Actors Studio was becoming, much too much, and therefore didn't satisfy not only my requirements, but when the people came here, uh, Arthur [Penn] and other people, I must say they were very dissatisfied with what they saw, and they kept after me to do something about it.
Fortunately the people here also had feelings of dissatisfaction, and therefore you try to work something out, which, on the whole, has begun to work.
In addition to the work that we do here, I must say that we like to see in our work what we call "projects", where actors bring in work of playwrights, or work of directors in the actors unit, so that the actor's work can be checked and evaluated, and the director's work and the playwright can get the benefit of that.
But to teach, the Institute is much better setup to teach. This is not a teaching process in the playwright and director's unit, and even in the actor's unit it's not quite a teaching process. It is more of a studio process, which means letting the people bring in their problem to solve, whereas at the Institute, we set the problems. That sets a "school" procedure, but here is a "studio" procedure, which is essentially different, though some of the aims are the same.
© 1996-2021 TheatrGROUP Method Acting Procedures – All rights reserved


The above image is cropped and scaled from a larger image. Click the image above to obtain the full version (approx. 2.6 MB).
Even without being told, you can probably guess that this image is taken from Elephant Valley. The structures surrounding the central "minibrot" in the large image resemble the elephants discussed earlier, and the Mandelbrot set has a habit of duplicating themes. Specifically, this image is centered near \(0.344+0.050i\), and is about 10-7 units across.


Published 04/24/2019 06:59:23 am at 04/24/2019 06:59:23 am in Industrial Bench Drill Press.
industrial bench drill press china industrial bench drill machine tool with iso 25mm jz 25 china drilling machine industrial drilling machine garrick industrial drill press mm from garrick machine tools garrick industrial bench drill press mm.
martlet maran bench drill press mm w toolswood martlet maran bench drill press mm w, ajax machine tools ajsbm industrial geared head pillar drill ph gear head bench pedestal drilling machines ajsbm industrial geared head pillar drill ph, usd anjie shun mini bench drill drill mini bench drill bench anjie shun mini bench drill drill mini bench drill bench drilling machine industrial grade high power, sterling industrial bench dril auctions online proxibid sterling industrial bench drill press model sp , drill presses heavy duty speed floor drill press, kst bench drill press drill press by maxnovo machine required fields, single phase mm industrial bench drill press buy bench drilling single phase mm industrial bench drill press, china high precision industrial drill press mm zz china high precision industrial drill press mm zz china drilling machine bench drilling machine, china mm single phase industrial bench drill press drilling china mm single phase industrial bench drill press drilling machine china bench drilling machine industrial bench drilling machine, duracraft industrial machines bench top drill press model dp lot of duracraft industrial machines bench top drill press model dp, drill press price jet industrial drill press zieslerinfo drill press price jet industrial .